About- Carcinoid tumors, now more commonly referred to as well-differentiated neuroendocrine tumors (NETs), are a type of tumor that develops from neuroendocrine cells. These cells are found throughout the body and have features of both nerve cells and hormone-producing cells. Carcinoid tumors are generally slow-growing, although some can grow more quickly and may spread to other parts of the body. They most commonly develop in the digestive tract, particularly in the small intestine, appendix, rectum, and stomach. They can also occur in the lungs and other organs. Some carcinoid tumors produce excess amounts of hormones or hormone-like substances. When these substances enter the bloodstream in significant amounts, they can cause a group of symptoms known as carcinoid syndrome. Carcinoid syndrome is more likely when a tumor has spread to the liver or other areas. Many carcinoid tumors do not cause noticeable symptoms in their early stages and may be discovered accidentally during an examination or procedure performed for another reason.
Symptoms vary depending on the location of the tumor, its size, whether it produces hormones, and whether it has spread to other parts of the body. Possible symptoms include:
Abdominal pain
Abnormal heartbeat or heart palpitations
Bowel obstruction
Chest pain
Diarrhea
Flushing of the face and neck
Low blood pressure
Nausea and vomiting
Rectal bleeding
Rectal pain
Shortness of breath
Wheezing
Unexplained weight changes
Some people may develop characteristic skin changes, including pink, red, or purple areas of skin, particularly in association with certain hormonal effects.
Carcinoid syndrome occurs when certain neuroendocrine tumors release excessive amounts of hormones and other substances into the bloodstream.
Common symptoms may include:
Recurrent flushing of the face and upper body
Watery diarrhea
Abdominal cramps or discomfort
Wheezing or difficulty breathing
Rapid heartbeat or palpitations
Changes in blood pressure
Facial or skin changes
Long-term exposure to certain substances released by the tumor can also affect the heart valves, potentially causing carcinoid heart disease.
Not everyone with a carcinoid tumor develops carcinoid syndrome.
The exact cause of most carcinoid tumors is not known. These tumors develop when neuroendocrine cells undergo changes that cause them to grow and multiply abnormally. In some cases, genetic conditions may increase the risk of developing neuroendocrine tumors. One inherited condition associated with an increased risk is multiple endocrine neoplasia type 1 (MEN 1). However, most people with carcinoid tumors do not have an inherited syndrome.
Carcinoid tumors commonly develop in the ileum, which is the lower portion of the small intestine. They may cause abdominal discomfort, changes in bowel habits, or intestinal obstruction.
Appendiceal carcinoid tumors are sometimes discovered unexpectedly after an appendix is removed for suspected appendicitis. Their behavior depends on their size, location, and other pathological features.
Rectal neuroendocrine tumors are often small and may be discovered during routine examinations such as colonoscopy. Larger tumors may cause rectal bleeding or discomfort.
A doctor may suspect a carcinoid tumor based on symptoms, medical history, physical examination, or findings from another medical test. Diagnosis may involve several tests.
If the suspected tumor is located in the digestive tract, an endoscopy or colonoscopy may allow the doctor to directly examine the affected area and obtain a tissue sample.
A biopsy involves removing a small amount of tissue for examination under a microscope. It can help confirm the diagnosis and provide information about the tumor’s characteristics. Pathologists may evaluate markers such as Ki-67, which helps determine how quickly the tumor cells are dividing and can assist in grading the tumor.
Some neuroendocrine tumors release substances that can be measured in the blood or urine. Depending on the suspected tumor and symptoms, doctors may test for substances such as:
Chromogranin A
5-HIAA, a breakdown product of serotonin that may be measured in urine or blood in appropriate circumstances
Specific hormones or other tumor-related substances
The choice of tests depends on the suspected tumor type and the person’s symptoms.
Surgery is often the main treatment when the tumor can be completely removed. The type of surgery depends on the tumor’s location and size. In some cases, removing the tumor may provide a cure, particularly when it has not spread.
Some small, slow-growing neuroendocrine tumors may be monitored closely rather than treated immediately. Regular follow-up may include imaging, laboratory tests, endoscopy, or other examinations.
Peptide receptor radionuclide therapy (PRRT) may be considered for certain advanced neuroendocrine tumors that have receptors capable of binding the treatment. A radioactive substance is attached to a molecule that targets these receptors, allowing radiation to be delivered directly to tumor cells.
Chemotherapy may be used for some neuroendocrine tumors, particularly tumors that are more aggressive or have specific characteristics. The choice of chemotherapy depends on the tumor type and grade.
When a neuroendocrine tumor has spread to the liver, treatment may include surgery, ablation, embolization procedures, systemic medicines, or other specialized treatments depending on the individual case.
Consult a healthcare professional if you have persistent or unexplained symptoms such as:
Recurrent abdominal pain
Persistent diarrhea
Unexplained flushing
Rectal bleeding
Repeated episodes of wheezing or breathing difficulty
Unexplained weight changes
Persistent nausea or vomiting
Seek urgent medical attention for severe abdominal pain, persistent vomiting, significant rectal or gastrointestinal bleeding, severe difficulty breathing, fainting, or symptoms suggesting bowel obstruction.
Carcinoid tumors are a type of neuroendocrine tumor and can be malignant. Although many are slow-growing, they can invade nearby tissues or spread to distant organs. Their behavior varies according to their location, grade, size, and other characteristics.
No. Many well-differentiated neuroendocrine tumors grow relatively slowly, but neuroendocrine cancers can have very different growth rates. Tumor grade and other pathological features help doctors estimate how aggressively a tumor may behave.
Some localized tumors can be completely removed with surgery and may be cured. Treatment and prognosis depend on the tumor’s location, size, grade, and whether it has spread.
Carcinoid syndrome is a collection of symptoms caused by substances released by certain neuroendocrine tumors. Typical symptoms include facial flushing, diarrhea, abdominal discomfort, wheezing, and changes in heart rate or blood pressure.
Yes. Some carcinoid tumors can spread to nearby lymph nodes or distant organs. The liver is a common site of spread for neuroendocrine tumors arising in the gastrointestinal tract.
No. Most people with carcinoid tumors do not develop carcinoid syndrome. It is more likely with certain hormone-producing tumors, particularly when the tumor has spread to the liver.
Medical Disclaimer: This information is intended for general educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. If you have symptoms or have been diagnosed with a neuroendocrine tumor, consult a qualified healthcare professional for individualized evaluation and treatment.